Carbimazole 5 mg Tablets
Authorisation PA22865/006/001 · Renata Pharmaceuticals (Ireland) Limited
- Licence holder
- Renata Pharmaceuticals (Ireland) Limited (all products →)
- Active substance
- Carbimazole
- Dosage form
- Tablet
- Route of administration
- Oral use
- ATC code
- H03BB01
- First authorised
- 18/11/2022
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Carbimazole: supply and approvals
6 authorised products on the HPRA list contain Carbimazole. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 19 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 19 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 19 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 4 years (since 18 November 2022). The HPRA list marks it as marketed in Ireland.
Other medicines with Carbimazole in Ireland
5 other products on the HPRA list contain Carbimazole, from 3 licence holders; 2 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Carbimazole 20 mg Tablets | Renata Pharmaceuticals (Ireland) Limited | National authorisation (PA) | Marketed |
| NeoMercazole 5 mg Tablets | Amdipharm Limited | National authorisation (PA) | Marketed |
| Carbimazole 20 mg Tablets | Essential-Healthcare Ltd. | National authorisation (PA) | Not marketed |
| Carbimazole 5 mg Tablets | Essential-Healthcare Ltd. | National authorisation (PA) | Not marketed |
| NeoMercazole 20 mg Tablets | Amdipharm Limited | National authorisation (PA) | Not marketed |
The licence holder
Renata Pharmaceuticals (Ireland) Limited holds 29 products on the HPRA list, with 17 different active substances; 9 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 20 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.